Table 3. Therapy-related complications and recurrence in groups B and C.
| Group | B (N = 20) | C (N = 19) | p value |
|---|---|---|---|
| Recurrence | 10% (2/20) | 10.5%(2/19) | 0.92 |
| Mortality | 0 | 15.9% (3/19) | 0.026 |
| Infection related | 0 | 10.5% (2/19) | - |
| Other cause | 5% (1/20) | 5.3% (1/19) | - |
| Complications | 0 | 31.6% (6/19) | 0.031 |
| Bleeding | - | 5.3% (1/19) | - |
| Skin necrosis | - | 5.3% (1/19) | - |
| Epigastric hernia | - | 21% (4/19) | - |
| Length of hospital stay (days) | 25.2 (±12.4) | 53.8 (±19.0) | 0.053 |
| Total duration antimicrobial therapy (days) | 18.4 (±9.0) | 36.2 (±25.1) | 0.026 |
| Follow-up time (days) | 146 (±32) | 127 (±50) | - |
Bold value indicates significance.